Interventional Oncology Devices – Market Insights – Europe
Despite the short-term challenges posed by the COVID-19 pandemic, the European market for interventional oncology devices will grow moderately through 2031. This will be driven largely by the expanding treatable patient populations, improved reimbursement, an increasing shift towards higher-priced technologies, and growing physician acceptance of interventional oncology procedures. However, growth in this market will be hindered by mixed clinical data, increasing-price competition, and ongoing cost constraints in the region which has led to a tempered adoption of interventional oncology devices.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in Europe from 2019–2031.
The COVID-19 pandemic had short-term consequences on the interventional oncology device market, but the market has begun to see a recovery towards pre-pandemic levels.
What procedure types of the interventional oncology market were impacted the most by COVID-19?
What will the recoveries look like for different procedure categories over the forecast period?
New ablation devices and technologies are rising in popularity among interventional oncologists.
How has the adoption of cryoablation changed the market dynamics in the microwave and RF ablation device categories?
What is the growth and adoption of IRE within the market and will this new technology overtake some of the existing product categories?
In which indications will these newer ablation devices, such as cryoablation and IRE, experience the fastest growth?
Ablation therapy procedures will continue to grow for the liver, kidney, and lung cancer indications, while novel indications such as prostate and pancreatic cancer represent new opportunities for growth.
What are the advantages and disadvantages of each type of ablation device offered by competitors and how do these differences affect adoption for different indications?
What are the major demographic, economic, and local trend differences across Europe that impact the adoption of these devices?
How will the growth vary across different ablation device categories?
Radioembolization spheres continue to represent the largest segment of the embolization particle market, although the microsphere and DEB markets will also experience growth over the forecast period.
What is the future of chemotherapy-radioembolization combination therapy and what are the studies being conducted to assess the efficacy and safety of the combination?
What factors are contributing to the growth of the European microsphere and DEB markets?
How will the uptake of other embolization particles impact the PVA particle market?
How will the adoption of bioresorbable microspheres and DEBs impact the adoption of existing products?
Table of contents
- Interventional Oncology Devices - Market Insights - Europe
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Factors Impacting the Interventional Oncology Device Market, by Product Type, Europe
- Interventional Oncology Device Market, by Product Type, Europe (USD), 2019u20132031
- Interventional Oncology Device Market Landscape, Europe (USD), 2021 and 2031
- Competitive Highlights
- Competitive Factors and Strategies, by Product Type, Europe
- Interventional Oncology Device Revenue Market Share Rankings, by Product Type, Europe, 2021
- Companies Mentioned
- Market Developments
- Recent Events in the Interventional Oncology Device Market, Europe
- Key Clinical Trials in the Interventional Oncology Device Market, Europe
- Emerging Products for the Interventional Oncology Market, Europe
- End-User Insights
- Geographies Covered
- Geographies Covered, Europe
- Average Currency Exchange Rates
- Procedures Covered
- Interventional Oncology Procedures Covered, Europe
- Products Covered
- Interventional Oncology Products Covered, Europe
- COVID-19 Updates
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Interventional Oncology Device Market, Europe
- Major Market Forecast Changes and Assumptions
- Interventional Oncology Device Market, by Product Type, Europe (USD), 2019u20132031 (Excluding COVID-19 Impact)
- Interventional Oncology Device Market, by Product Type, Europe (USD), 2019u20132031 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Interventional Oncology Device Market, Europe
- COVID-19 Financial Impact and Competitor Insights
- Market Impact
- Interventional Oncology Device Market
- Market Highlights
- Factors Impacting the Interventional Oncology Device Market, by Product Type, Europe
- Interventional Oncology Device Market, by Product Type, Europe (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Interventional Oncology Procedures, by Procedure Type, Europe, 2019u20132031
- Interventional Oncology Procedures, by Indication, Europe, 2019u20132031
- Interventional Oncology Procedures, by Country, Europe, 2019u20132031
- Interventional Oncology Device Market, by Product Type, Europe (USD and EUR), 2019u20132031
- Interventional Oncology Device Market Growth, by Product Type, Europe, 2020u20132031
- Interventional Oncology Device Market, by Country, Europe (USD), 2019u20132031
- Interventional Oncology Device Market, by Country, Europe (EUR and GBP), 2019u20132031
- Interventional Oncology Device Market Growth, by Country, Europe, 2020u20132031
- Competitive Highlights
- Market Shares
- Interventional Oncology Device Revenue Market Shares, Europe, 2021
- Interventional Oncology Device Revenue Market Shares, by Product Type, Europe, 2021
- Interventional Oncology Device Revenue Market Shares, by Country, Europe, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, Europe
- Market Developments
- Recent Events in the Interventional Oncology Device Market, Europe
- Key Clinical Trials in the Interventional Oncology Device Market, Europe
- Emerging Products for the Interventional Oncology Market, Europe
- Market Highlights
- Ablation Device Market
- Market Highlights
- Ablation Device Market, by Product Type, Europe (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Ablation Procedures, by Indication, Europe, 2019u20132031
- Ablation Procedures, by Product Type, Europe, 2019u20132031
- Ablation Procedures, by Country, Europe, 2019u20132031
- Primary Liver Cancer Ablation Procedures, by Product Type, Europe, 2019u20132031
- Primary Liver Cancer Ablation Procedures, by Country, Europe, 2019u20132031
- Secondary Liver Cancer Ablation Procedures, by Product Type, Europe, 2019u20132031
- Secondary Liver Cancer Ablation Procedures, by Country, Europe, 2019u20132031
- Kidney Cancer Ablation Procedures, by Product Type, Europe, 2019u20132031
- Kidney Cancer Ablation Procedures, by Country, Europe, 2019u20132031
- Lung Cancer Ablation Procedures, by Product Type, Europe, 2019u20132031
- Lung Cancer Ablation Procedures, by Country, Europe, 2019u20132031
- Ablation Device Market, by Product Type, Europe (USD), 2019u20132031
- Ablation Device Market, by Product Type, Europe (EUR), 2019u20132031
- Ablation Device Market Growth, by Product Type, Europe, 2020u20132031
- Ablation Device Market, by Country, Europe (USD), 2019u20132031
- Ablation Device Market, by Country, Europe (EUR and GBP), 2019u20132031
- Ablation Device Market Growth, by Country, Europe, 2020u20132031
- RF Ablation Procedures, by Country, Europe, 2019u20132031
- RF Ablation Procedures, by Indication, Europe, 2019u20132031
- RF Ablation Device Market, by Country, Europe (USD), 2019u20132031
- RF Ablation Device Market, by Country, Europe (EUR, and GBP), 2019u20132031
- RF Ablation Device Market Growth, by Country, Europe, 2020u20132031
- Microwave Ablation Procedures, by Indication, Europe, 2019u20132031
- Microwave Ablation Procedures, by Country, Europe, 2019u20132031
- Microwave Ablation Device Market, by Country, Europe (USD), 2019u20132031
- Microwave Ablation Device Market, by Country, Europe(EUR and GBP), 2019u20132031
- Microwave Ablation Device Market Growth, by Country, Europe 2020u20132031
- Cryoablation Procedures, by Indication, Europe, 2019u20132031
- Cryoablation Procedures, by Country, Europe, 2019u20132031
- Cryoablation Device Market, by Country, Europe (USD), 2019u20132031
- Cryoablation Ablation Device Market, by Country, Europe(EUR and GBP), 2019u20132031
- Cryoablation Device Market Growth, by Country, Europe, 2020u20132031
- IRE Ablation Device Market, by Indication, Europe, 2019u20132031
- IRE Ablation Procedures, by Country, Europe, 2019u20132031
- IRE Ablation Device Market, by Country, Europe (USD), 2019u20132031
- IRE Ablation Device Market, by Country, Europe(EUR and GBP), 2019u20132031
- IRE Ablation Device Market Growth, by Country, Europe (USD), 2020u20132031
- Competitive Highlights
- Market Shares
- Ablation Device Revenue Market Shares, Europe, 2021
- Ablation Device Revenue Market Shares, by Product Type, Europe, 2021
- Ablation Device Revenue Market Shares, by Country, Europe, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, Europe
- Market Highlights
- Embolization Device Market
- Market Highlights
- Embolization Particle Market, by Product Type, Europe (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Embolization Particle Procedures, by Indication, Europe, 2019u20132031
- Embolization Particle Procedures, by Country, Europe, 2019u20132031
- Embolization Particle Procedures, by Product Type, Europe, 2019u20132031
- Liver Cancer Embolization Particle Procedures, by Product Type, Europe, 2019u20132031
- Kidney Cancer Embolization Particle Procedures, by Product Type, Europe, 2019u20132031
- Embolization Particle Market, by Product Type, Europe (USD), 2019u20132031
- Embolization Particle Market, by Product Type, Europe (EUR), 2019u20132031
- Embolization Particle Market Growth, by Product Type, Europe, 2020u20132031
- Embolization Particle Market, by Country, Europe (USD), 2019u20132031
- Embolization Particle Market, by Country, Europe (EUR and GBP), 2019u20132031
- Embolization Particle Market Growth, by Country, Europe, 2020u20132031
- Radioembolization Procedures, by Indication, Europe, 2019u20132031
- Radioembolization Procedures, by Country, Europe, 2019u20132031
- Radioembolization Sphere Market, by Country, Europe (USD), 2019u20132031
- Radioembolization Sphere Market, by Country, Europe(EUR and GBP), 2019u20132031
- Radioembolization Sphere Market Growth, by Country, Europe, 2020u20132031
- DEB Procedures, by Indication, Europe, 2019u20132031
- DEB Procedures, by Country, Europe, 2019u20132031
- DEB Sphere Market, by Country, Europe (USD), 2019u20132031
- DEB Sphere Market, by Country, Europe(EUR and GBP), 2019u20132031
- DEB Sphere Market Growth, by Country, Europe , 2020u20132031
- Microsphere Procedures, by Indication, Europe, 2019u20132031
- Microsphere Procedures, by Country, Europe, 2019u20132031
- Microsphereu00a0Market, by Country, Europe (USD), 2019u20132031
- Microsphereu00a0Market, by Country, Europe (EUR, and GBP), 2019u20132031
- Microsphereu00a0Market Growth, by Country, Europe, 2020u20132031
- PVA Particle Procedures, by Indication, Europe, 2019u20132031
- PVA Particle Procedures, by Country, Europe, 2019u20132031
- PVA Particleu00a0Market, by Country, Europe (USD), 2019u20132031
- PVAu00a0Particleu00a0Market, by Country, Europe (EUR, and GBP), 2019u20132031
- PVA Particleu00a0Market Growth, by Country, Europe, 2020u20132031
- Competitive Highlights
- Market Shares
- Embolization Particle Revenue Market Shares, Europe, 2021
- Embolization Particle Revenue Market Shares, by Product Type, Europe, 2021
- Embolization Particle Revenue Market Shares, by Country, Europe, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, Europe
- Market Highlights
- Accessory Device Market
- Market Highlights
- Accessory Device Market, by Product Type, Europe (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Accessory Device Market, by Product Type, Europe (USD), 2019u20132031
- Accessory Device Market, by Product Type, Europe (EUR), 2019u20132031
- Accessory Device Market Growth, by Product Type, Europe, 2020u20132031
- Accessory Device Market, by Country, Europe (USD), 2019u20132031
- Accessory Device Market, by Country, Europe (EUR and GBP), 2019u20132031
- Accessory Device Market Growth, by Country, Europe, 2020u20132031
- Guide Catheter Market, by Country, Europe (USD), 2019u20132031
- Guide Catheter Market, by Country, Europe (EUR and GBP), 2019u20132031
- Guide Catheter Market Growth, by Country, Europe (USD), 2020u20132031
- Microcatheter Device Market, by Country, Europe (USD), 2019u20132031
- Microcatheter Device Market, by Country, Europe (EUR and GBP), 2019u20132031
- Microcatheter Device Market Growth, by Country, Europe (USD), 2020u20132031
- Angiography Catheter Device Market, by Country, Europe (USD), 2019u20132031
- Angiography Catheter Device Market, by Country, Europe (EUR and GBP), 2019u20132031
- Angiography Catheter Device Market Growth, by Country, Europe (USD), 2020u20132031
- Guidewire Device Market, by Country, Europe (USD), 2019u20132031
- Guidewire Device Market, by Country, Europe (EUR and GBP), 2019u20132031
- Guidewire Device Market Growth, by Country, Europe (USD), 2020u20132031
- Sheath Device Market, by Country, Europe (USD), 2019u20132031
- Sheath Device Market, by Country, Europe (EUR and GBP), 2019u20132031
- Sheath Device Market Growth, by Country, Europe (USD), 2020u20132031
- Competitive Highlights
- Market Shares
- Accessory Device Revenue Market Shares, Europe, 2021
- Accessory Devices Revenue Market Shares, by Product Type, Europe, 2021
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, Europe
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Sangeetha Iyer is a senior analyst within the Cardiovascular Medtech Insights team at Decision Resource Group, specializing in structural heart closure and vascular access device markets across the Asia Pacific region, as well as medical device pricing and regulations in China and Japan. Sangeetha has represented India at the European Society of Cardiology conference in Greece (2016) and Sweden (2017), where her research poster was awarded the top prize. Sangeetha holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Sangeetha on twitter: @Slyer_DRG